Vaxcyte, Inc. Common Stock
Symbol: PCVX (NASDAQ)
42.79
▲ (1.03%) 0.435
Company Description:
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
Key Stats
- Today's Open: $42.36
- Today's High: $42.789
- Today's Low: $42.36
- Today's Volume: 327
- Yesterday Close: $42.35
- Yesterday High: $43.45
- Yesterday Low: $42.15
- Yesterday Volume: 883.15K
- Last Min Volume: 15
- Last Min High: $42.785
- Last Min Low: $42.785
- Last Min VWAP: $42.785
Company Profile
- Name: Vaxcyte, Inc. Common Stock
- Website: https://www.vaxcyte.com
- Listed Date: 2020-06-12
- Location: SAN CARLOS, CA
- Market Status: Active
- CIK Number: 0001649094
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $5.57B
- Round Lot: 100
- Outstanding Shares: 129.82M
- Asset Type: CS
RECENT FILINGS FOR PCVX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-30 | 8-K | View |
| 2025-09-10 | 4 | View |
| 2025-09-10 | 4 | View |
| 2025-09-10 | 4 | View |
| 2025-09-10 | 4 | View |
| 2025-09-10 | 4 | View |
| 2025-09-08 | SCHEDULE 13G/A | View |
| 2025-09-04 | 4 | View |
| 2025-09-04 | 4 | View |
| 2025-09-04 | 4 | View |
| 2025-09-04 | 4 | View |
| 2025-09-04 | 4 | View |
| 2025-08-29 | 4 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-06 | 10-Q | View |
| 2025-08-06 | 8-K | View |
| 2025-08-06 | SCHEDULE 13G/A | View |
| 2025-06-17 | 8-K | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
Latest News on PCVX